Treatment-Refractory Eosinophilic Esophagitis Successfully Managed with benralizumab: A Case Presentation and literature review

[1] SYVERSON E. P., HAIT E. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis, Gastroenterol. Hepatol., vol. 18, no. 4, pp. 207–212, Apr. 2022. Search in Google Scholar

[2] COLLINS M. H., CAPOCELLI K., YANG G.-Y. Eosinophilic Gastrointestinal Disorders Pathology, Front. Med., vol. 4, p. 261, 2017. Search in Google Scholar

[3] ALLIN K. H., POULSEN G., MELGAARD D., FRANDSEN T., JESS T., KRARUP A. L. Eosinophilic oesophagitis in Denmark: Population-based incidence and prevalence in a nationwide study from 2008 to 2018, United Eur. Gastroenterol. J., vol. 10, no. 7, pp. 640–650, Sep. 2022. Search in Google Scholar

[4] MUIR A., FALK G. W. Eosinophilic Esophagitis: A Review, JAMA, vol. 326, no. 13, pp. 1310–1318, Oct. 2021. Search in Google Scholar

[5] FEO-ORTEGA S., LUCENDO A. J. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician, Ther. Adv. Gastroenterol., vol. 15, p. 17562848211068665, 2022. Search in Google Scholar

[6] BEVERIDGE C., FALK G. W. Novel Therapeutic Approaches to Eosinophilic Esophagitis, Gastroenterol. Hepatol., vol. 16, no. 6, pp. 294–301, Jun. 2020. Search in Google Scholar

[7] DOBBINS J. W., SHEAHAN D. G., BEHAR J. Eosinophilic gastroenteritis with esophageal involvement, Gastroenterology, vol. 72, no. 6, pp. 1312–1316, Jun. 1977. Search in Google Scholar

[8] FURUTA G. T., KATZKA D. A. Eosinophilic Esophagitis, N. Engl. J. Med., vol. 373, no. 17, pp. 1640–1648, Oct. 2015. Search in Google Scholar

[9] DELLON E. S., GONSALVES N., HIRANO I., FURUTA G. T., LIACOURAS C. A., KATZKA D. A. ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE), Am. J. Gastroenterol., vol. 108, no. 5, pp. 679–692, May 2013. Search in Google Scholar

[10] DELLON E. S., HIRANO I. Epidemiology and Natural History of Eosinophilic Esophagitis, Gastroenterology, vol. 154, no. 2, pp. 319-332.e3, Jan. 2018. Search in Google Scholar

[11] PITLICK M. M., LI J. T., PONGDEE T. Current and emerging biologic therapies targeting eosinophilic disorders, World Allergy Organ. J., vol. 15, no. 8, p. 100676, Aug. 2022. Search in Google Scholar

[12] HIRANO I., FURUTA G. T. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis, Gastroenterology, vol. 158, no. 4, pp. 840–851, Mar. 2020. Search in Google Scholar

[13] LUCENDO A. J. et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults, United Eur. Gastroenterol. J., vol. 5, no. 3, pp. 335–358, Apr. 2017. Search in Google Scholar

[14] MAYERHOFER C., KAVALLAR A. M., ALDRIAN D., LINDNER A. K., MÜLLER T., VOGEL G. F. Efficacy of Elimination Diets in Eosinophilic Esophagitis: A Systematic Review and Meta-analysis, Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc., vol. 21, no. 9, pp. 2197-2210.e3, Aug. 2023. Search in Google Scholar

[15] KUANG F. L. et al. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease, J. Allergy Clin. Immunol. Pract., vol. 10, no. 6, pp. 1598-1605.e2, Jun. 2022. Search in Google Scholar